COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2238: Articles 22371-22380  | Next

Convalescent plasma as potential therapy for severe COVID-19 pneumonia.
Valentini, R., Dupont, J., Fernandez, J., Solimano, J., Palizas, F., Riveros, D., Saul, P., Dupont, L., Medina, J., Falasco, V., Fornillo, F., Laviano, J., Maymo, D., Gotta, D., Martinez, A., Bonvehi, P.
10.1101/2020.09.01.20184390 — Posted: 2020-09-07
Modeling COVID-19 Transmission in Africa: Country-wise Projections of Total and Severe Infections Under Different Lockdown Scenarios
Frost, I., Craig, J., Osena, G., Hauck, S., Kalanxhi, E., Schueller, E., Gatalo, O., Yany, Y., Tseng, K., Lin, G., Klein, E.
10.1101/2020.09.04.20188102 — Posted: 2020-09-07
Regression Models for Predictions of COVID-19 New Cases and New Deaths Based on May/June Data in Ethiopia
Argawu, A. S.
10.1101/2020.09.04.20188094 — Posted: 2020-09-07
The link between vitamin D deficiency and Covid-19 in a large population
Israel, A., Cicurel, A. A., Feldhamer, I., Dror, Y., Giveon, S. M., Gillis, D., Strich, D., Lavie, G.
10.1101/2020.09.04.20188268 — Posted: 2020-09-07 Discussion: Onsite
Cooperative efforts on developing vaccines and therapies for COVID-19
Basso, F. G., de Paulo, A. F., Porto, G., Pereira, C. G.
10.1101/2020.09.06.282145 — Posted: 2020-09-06
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-COV-2
Hassan, S. S., Attrish, D., Ghosh, S., Pal Choudhury, P., Uversky, V. N., Uhal, B., Lundstrom, K., Rezaei, N., Aljabali, A. A. A., Seyran, M., Pizzol, D., Adadi, P., Abd El-Aziz, T. M., Soares, A., Kandimalla, R., Tambuwala, M., Lal, A., Azad, G. K., P. Sherchan, S., Baetas-da-Cruz, W., Palu, G., Brufsky, A.
10.1101/2020.09.06.284976 — Posted: 2020-09-06
Long-term survival of salmon-attached SARS-CoV-2 at 4 degree as a potential source of transmission in seafood markets
Dai, M., Li, H., Yan, N., Huang, J., Zhao, L., Xu, S., Jiang, S., Pan, C., Liao, M.
10.1101/2020.09.06.284695 — Posted: 2020-09-06
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide
Srivastava, S., Verma, S., Kamthania, M., Agarwal, D., Saxena, A. K., Kolbe, M., Singh, S., Kotnis, A., Rathi, B., Nayar, S. A., Shin, H.-J., Vashisht, K., Pandey, K. C.
10.1101/2020.09.06.284992 — Posted: 2020-09-06
New insights into nCOVID-19 binding domain and its cellular receptors
Garg, A., Kumar, G., Sinha, S.
10.1101/2020.09.06.285023 — Posted: 2020-09-06
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
Moore, A. C., Dora, E. G., Peinovich, N., Tucker, K. P., Lin, K., Cortese, M., Tucker, S.
10.1101/2020.09.04.283853 — Posted: 2020-09-06 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).